Search Results 611-620 of 16260 for Chronic Lymphocytic Leukemia
Acute lymphoblastic leukemia (ALL) is the most common cancer in children. It is now possible to cure over 90% of these children with drug therapy. One of ...
This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib ...
... Chronic Lymphocytic Leukemia Rochester, MN. The purpose of this study is to ... CLL as well as non-CLL patients. Paclitaxel Albumin-Stabilized ...
Patients must have any one of the following diagnosis: Monoclonal B-cell lymphocytosis. Chronic lymphocytic leukemia/small lymphocytic lymphoma. B-cell Non ...
Nearly 40% of patients with chronic myelomonocytic leukemia have a mutation in the ASXL1 gene. "Unfortunately, patients with ASXL1 mutations do not fare well ...
... chronic hepatitis B or C) or uncontrolled chronic degenerative disease (e.g. diabetes) that may preclude the delivery of treatment determined by treating ...
... chronic kidney disease: a prespecified analysis from the DAPA-CKD trial. ... Nephrotic syndrome in chronic lymphocytic leukemia. A Paraneoplastic ...
Calaspargase pegol-mknl injection is used together with other cancer medicines to treat patients with acute lymphoblastic leukemia (ALL), a type of white blood ...
Pegaspargase injection is used in combination with other cancer medicines to treat acute lymphoblastic leukemia (ALL), a type of blood cancer that affects the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.